Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

LIFECORE BIOMEDICAL, INC. (LFCR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

LIFECORE BIOMEDICAL, INC. (LFCR), most recent 12 months reported: revenue $128.87M, net loss $38.72M, free cash flow -$13.62M. Latest balance sheet on file: liquid cash $17.24M, total debt $154.1M, net cash -$136.86M. From SEC filings. Others in Pharmaceutical Preparations: HERON THERAPEUTICS, INC. /DE/ · Karyopharm Therapeutics Inc. · Elite Pharmaceuticals, Inc. · Zevra Therapeutics, Inc. · Gyre Therapeutics, Inc. · Arcus Biosciences, Inc. · ARS Pharmaceuticals, Inc. · Eton Pharmaceuticals, Inc.

Stock screener

Watchlist